132 related articles for article (PubMed ID: 8834447)
21. Destruction of articular cartilage by alpha 2 macroglobulin elastase complexes: role in rheumatoid arthritis.
Moore AR; Appelboam A; Kawabata K; Da Silva JA; D'Cruz D; Gowland G; Willoughby DA
Ann Rheum Dis; 1999 Feb; 58(2):109-13. PubMed ID: 10343526
[TBL] [Abstract][Full Text] [Related]
22. Human osteoarthritis synovial fluid and joint cartilage contain both aggrecanase- and matrix metalloproteinase-generated aggrecan fragments.
Struglics A; Larsson S; Pratta MA; Kumar S; Lark MW; Lohmander LS
Osteoarthritis Cartilage; 2006 Feb; 14(2):101-13. PubMed ID: 16188468
[TBL] [Abstract][Full Text] [Related]
23. Pathways of aggrecan processing in joint tissues. Implications for disease mechanism and monitoring.
Sandy JD; Plaas AH; Koob TJ
Acta Orthop Scand Suppl; 1995 Oct; 266():26-32. PubMed ID: 8553857
[No Abstract] [Full Text] [Related]
24. Identification of the metalloproteinase stromelysin in the physis.
Armstrong AL; Barrach HJ; Ehrlich MG
J Orthop Res; 2002 Mar; 20(2):289-94. PubMed ID: 11918308
[TBL] [Abstract][Full Text] [Related]
25. Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: relationship to mediators of systemic and local inflammation.
Fraser A; Fearon U; Billinghurst RC; Ionescu M; Reece R; Barwick T; Emery P; Poole AR; Veale DJ
Arthritis Rheum; 2003 Nov; 48(11):3085-95. PubMed ID: 14613270
[TBL] [Abstract][Full Text] [Related]
26. Sensitivity of monoclonal antibody, 5-D-4, for the detection of aggrecan, aggrecan fragments, and keratan sulfate.
Saphos CA; Dey P; Lark MW; Moore VL
Agents Actions; 1993; 39 Spec No():C154-6. PubMed ID: 7506001
[TBL] [Abstract][Full Text] [Related]
27. The structure of aggrecan fragments in human synovial fluid. Evidence for the involvement in osteoarthritis of a novel proteinase which cleaves the Glu 373-Ala 374 bond of the interglobular domain.
Sandy JD; Flannery CR; Neame PJ; Lohmander LS
J Clin Invest; 1992 May; 89(5):1512-6. PubMed ID: 1569188
[TBL] [Abstract][Full Text] [Related]
28. Human granzyme B degrades aggrecan proteoglycan in matrix synthesized by chondrocytes.
Froelich CJ; Zhang X; Turbov J; Hudig D; Winkler U; Hanna WL
J Immunol; 1993 Dec; 151(12):7161-71. PubMed ID: 8258716
[TBL] [Abstract][Full Text] [Related]
29. Immunolocalization of the cleavage of the aggrecan core protein at the Asn341-Phe342 bond, as an indicator of the location of the metalloproteinases active in the lysis of the rat growth plate.
Lee ER; Lamplugh L; Leblond CP; Mordier S; Magny MC; Mort JS
Anat Rec; 1998 Sep; 252(1):117-32. PubMed ID: 9737748
[TBL] [Abstract][Full Text] [Related]
30. A short-term pharmacodynamic model for monitoring aggrecanase activity: injection of monosodium iodoacetate (MIA) in rats and assessment of aggrecan neoepitope release in synovial fluid using novel ELISAs.
Swearingen CA; Chambers MG; Lin C; Marimuthu J; Rito CJ; Carter QL; Dotzlaf J; Liu C; Chandrasekhar S; Duffin KL; Mitchell PG; Durham TB; Wiley MR; Thirunavukkarasu K
Osteoarthritis Cartilage; 2010 Sep; 18(9):1159-66. PubMed ID: 20633676
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of bovine nasal cartilage degradation by selective matrix metalloproteinase inhibitors.
Bottomley KM; Borkakoti N; Bradshaw D; Brown PA; Broadhurst MJ; Budd JM; Elliott L; Eyers P; Hallam TJ; Handa BK; Hill CH; James M; Lahm HW; Lawton G; Merritt JE; Nixon JS; Röthlisberger U; Whittle A; Johnson WH
Biochem J; 1997 Apr; 323 ( Pt 2)(Pt 2):483-8. PubMed ID: 9163342
[TBL] [Abstract][Full Text] [Related]
32. Development of a cleavage-site-specific monoclonal antibody for detecting metalloproteinase-derived aggrecan fragments: detection of fragments in human synovial fluids.
Fosang AJ; Last K; Gardiner P; Jackson DC; Brown L
Biochem J; 1995 Aug; 310 ( Pt 1)(Pt 1):337-43. PubMed ID: 7544117
[TBL] [Abstract][Full Text] [Related]
33. A longitudinal study of cartilage matrix metabolism in patients with cruciate ligament rupture--synovial fluid concentrations of aggrecan fragments, stromelysin-1 and tissue inhibitor of metalloproteinase-1.
Dahlberg L; Fridén T; Roos H; Lark MW; Lohmander LS
Br J Rheumatol; 1994 Dec; 33(12):1107-11. PubMed ID: 8000736
[TBL] [Abstract][Full Text] [Related]
34. Normal and shear interactions between hyaluronan-aggrecan complexes mimicking possible boundary lubricants in articular cartilage in synovial joints.
Seror J; Merkher Y; Kampf N; Collinson L; Day AJ; Maroudas A; Klein J
Biomacromolecules; 2012 Nov; 13(11):3823-32. PubMed ID: 23074968
[TBL] [Abstract][Full Text] [Related]
35. In vivo expression of stromelysin in synovium and cartilage of rabbits injected intraarticularly with interleukin-1 beta.
Hutchinson NI; Lark MW; MacNaul KL; Harper C; Hoerrner LA; McDonnell J; Donatelli S; Moore V; Bayne EK
Arthritis Rheum; 1992 Oct; 35(10):1227-33. PubMed ID: 1418008
[TBL] [Abstract][Full Text] [Related]
36. Release of hyaluronan and hyaladherins (aggrecan G1 domain and link proteins) from articular cartilage exposed to ADAMTS-4 (aggrecanase 1) or ADAMTS-5 (aggrecanase 2).
Chockalingam PS; Zeng W; Morris EA; Flannery CR
Arthritis Rheum; 2004 Sep; 50(9):2839-48. PubMed ID: 15457452
[TBL] [Abstract][Full Text] [Related]
37. Metalloproteinases, tissue inhibitor, and proteoglycan fragments in knee synovial fluid in human osteoarthritis.
Lohmander LS; Hoerrner LA; Lark MW
Arthritis Rheum; 1993 Feb; 36(2):181-9. PubMed ID: 8431206
[TBL] [Abstract][Full Text] [Related]
38. Aggrecan degradation in human cartilage. Evidence for both matrix metalloproteinase and aggrecanase activity in normal, osteoarthritic, and rheumatoid joints.
Lark MW; Bayne EK; Flanagan J; Harper CF; Hoerrner LA; Hutchinson NI; Singer II; Donatelli SA; Weidner JR; Williams HR; Mumford RA; Lohmander LS
J Clin Invest; 1997 Jul; 100(1):93-106. PubMed ID: 9202061
[TBL] [Abstract][Full Text] [Related]
39. Induction of increased levels of proteoglycan fragments in synovial fluid (SF) and increased levels of stromelysin in cartilage, synovium and SF by intraarticular injection of canine monocyte conditioned medium into dogs.
Lark MW; MacNaul KA; Donatelli S; McDonnell J; Hoerrner LA; Stevens KA; Saphos CA; Bayne EK; Hutchinson NI; Moore VL
J Rheumatol; 1994 Sep; 21(9):1716-24. PubMed ID: 7799356
[TBL] [Abstract][Full Text] [Related]
40. Proteoglycan turnover in the sclera of normal and experimentally myopic chick eyes.
Rada JA; Achen VR; Rada KG
Invest Ophthalmol Vis Sci; 1998 Oct; 39(11):1990-2002. PubMed ID: 9761277
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
